1-13 of 13
Li Xue
Close
Sort by
Journal Articles

Venetoclax, Cladribine and Cytarabine for the Treatment of Relapse/Refractory Acute Lymphoblastic Leukemia: Interim Analysis of a Phase 2 Trial

Yan-yan Li, Hai-xia Zhou, Si-man Huang, Chao-Ling Wan, Ming-zhu Xu, Wen-jie Gong, Chong-Sheng Qian, De-pei Wu, Haiping Dai, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 1506.
https://doi.org/10.1182/blood-2023-185312
Published: 2023
Journal Articles

RUNX1 Mutation Does Not Significantly Impact the Outcome of Newly Diagnosedadult AML: A Retrospective Study of Chinese AML Patients

Chao-Ling Wan, Yuan-Hong Huang, Si-Man Huang, Tong-Tong Zhang, Kai-Wen Tan, Yan Qiu, Xiang-Dong Shen, Shuai-Shuai Ge, Han-Yu Cao, Yan-Yan Li, Songbai Liu, Qiao-Cheng Qiu, Haiping Dai, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 4216.
https://doi.org/10.1182/blood-2023-185390
Published: 2023
Journal Articles

Recombinant Human Thrombopoietin Combined with Thrombopoietin Receptor Agonists Can Facilitate the Recovery of Platelet after Allogeneic HSCT

Meng Cheng, Chong-Sheng Qian, Hai-xia Zhou, Mingzhu Xu, Wen-jie Gong, Aining Sun, De-pei Wu, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 5451.
https://doi.org/10.1182/blood-2023-191091
Published: 2023
Journal Articles

Safety and Efficacy of CD22/ CD19 CAR-T and Auto-HSCT “Sandwich” Strategy As Consolidation Therapy for Ph Negative B Cell Acute Lymphoblastic Leukemia

Yan Qiu, Chong-Sheng Qian, Hai-Xia Zhou, Ming-Zhu Xu, Li-Qing Kang, Ai-Ning Sun, De-Pei Wu, Lei Yu, Sheng-Li Xue
Journal: Blood
Blood (2023) 142 (Supplement 1): 3481.
https://doi.org/10.1182/blood-2023-182728
Published: 2023
Journal Articles

Improved Prevention and Treatment Strategy of Differentiation Syndrome Contribute to Reduce Early Death of Patients with Acute Promyelocytic Leukemia

Qian Wu, De-Pei Wu, Suning Chen, Xiaofei Yang, Jingren Zhang, Mengxing Xue, Xueqing Dou, Sheng-Li Xue, Huiying Qiu, Xiaowen Tang, Yue Han, Jianhong Fu, Xuefeng He
Journal: Blood
Blood (2023) 142 (Supplement 1): 1528.
https://doi.org/10.1182/blood-2023-182749
Published: 2023
Journal Articles

Venetoclax with decitabine as frontline treatment in younger adults with newly diagnosed ELN adverse-risk AML

Clinical Trials & Observations
Jundan Xie, Xiebing Bao, Sheng-Li Xue, Hongjie Shen, Jiannong Cen, Li Yao, Jinlan Pan, Mingqing Zhu, Dandan Liu, Xiaohui Hu, Qian Wu, Jingren Zhang, Haiping Dai, Yanglin Cao, Xuefeng He, Xiaowen Tang, Ai-Ning Sun, Ying Wang, Jianhong Fu, Huiying Qiu, Xiaofei Yang, Suning Chen, Depei Wu
Journal: Blood
Blood (2023) 142 (15): 1323–1327.
https://doi.org/10.1182/blood.2023020102
Published: 2023
Includes: Supplemental data
Journal Articles

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse

Li-Xue Yang, Cheng-Tao Zhang, Meng-Ying Yang, Xue-Hong Zhang, Hong-Chen Liu, Chen-Hui Luo, Yue Jiang, Zhang-Man Wang, Zhong-Yin Yang, Zhao-Peng Shi, Yi-Ci Yang, Ruo-Qu Wei, Li Zhou, Jun Mi, Ai-Wu Zhou, Zhi-Rong Yao, Li Xia, Jin-Song Yan, Ying Lu
Journal: Blood
Blood (2023) 141 (7): 766–786.
https://doi.org/10.1182/blood.2022017046
Published: 2023
Includes: Supplemental data
Journal Articles

PRMT1-mediated FLT3 arginine methylation promotes maintenance of FLT3-ITD + acute myeloid leukemia

Xin He, Yinghui Zhu, Yi-Chun Lin, Min Li, Juan Du, Haojie Dong, Jie Sun, Lei Zhu, Hanying Wang, Zonghui Ding, Lei Zhang, Lianjun Zhang, Dandan Zhao, Zhihao Wang, Herman Wu, Han Zhang, Wenjuan Jiang, Yang Xu, Jian Jin, Yudao Shen, Jeff Perry, Xinyang Zhao, Bin Zhang, Songbai Liu, Sheng-Li Xue, Binghui Shen, Chun-Wei Chen, Jianjun Chen, Samer Khaled, Ya-Huei Kuo, Guido Marcucci, Yun Luo, Ling Li
Journal: Blood
Blood (2019) 134 (6): 548–560.
https://doi.org/10.1182/blood.2019001282
Published: 2019
Includes: Supplemental data
Journal Articles

A Single Gene-Mediated Perturbation of the Human Genome Leads to Malignant Transformation in a Murine Transgenic Model

Jianhong Lin, MD MSc, Chun Yang, MD PhD, Li Xue, MD PhD, Zhenkui Wang, MD PhD, Yan Xu, MD, Mehmet Kemal Samur, PhD, Jianjun Zhao, MD, Ariel Kwart, BS, Masood A. Shammas, PhD, Xiaofeng Jiang, MD PhD, Wong Kwok-Kin, MD PhD, Ruben D. Carrasco, MD PhD, Kenneth C Anderson, MD, Nikhil Munshi, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4410.
https://doi.org/10.1182/blood.V130.Suppl_1.4410.4410
Published: 2017
Journal Articles

EKLF/KLF1-regulated cell cycle exit is essential for erythroblast enucleation

Merlin Nithya Gnanapragasam, Kathleen E. McGrath, Seana Catherman, Li Xue, James Palis, James J. Bieker
Journal: Blood
Blood (2016) 128 (12): 1631–1641.
https://doi.org/10.1182/blood-2016-03-706671
Published: 2016
Includes: Supplemental data
Journal Articles

Interleukin-6 Reduces Erythroid Development and Mitochondrial Membrane Potential In Human Erythroleukemic Cells

Bryan J. McCranor, PhD, MinJung Kim, PhD, Nicole M Cruz, Qian-Li Xue, PhD, Alan E. Berger, PhD, Jeremy D. Walston, M.D., Curt I. Civin, M.D., Cindy N. Roy, PhD
Journal: Blood
Blood (2013) 122 (21): 3420.
https://doi.org/10.1182/blood.V122.21.3420.3420
Published: 2013
Journal Articles

Interleukin-6 Is a Significant Modifier of the Anemia Associated with Aging in Mice.

Bryan J. McCranor, PhD, Jacqueline M. Langdon, Olivier D. Prince, M.D., Qilu Yu, Ph.D., Alan E. Berger, PhD, Chris Cheadle, PhD, Curt I. Civin, MD, Jeremy D. Walston, M.D., Qian-Li Xue, PhD, Cindy N. Roy, PhD
Journal: Blood
Blood (2012) 120 (21): 2094.
https://doi.org/10.1182/blood.V120.21.2094.2094
Published: 2012
Journal Articles

Regulatory elements of the EKLF gene that direct erythroid cell-specific expression during mammalian development

Li Xue, Xiaoyong Chen, Yanjie Chang, James J. Bieker
Journal: Blood
Blood (2004) 103 (11): 4078–4083.
https://doi.org/10.1182/blood-2003-09-3231
Published: 2004